Cellectis filed reports with the SEC and its stock was listed on Nasdaq on September 15, 2026.
1 report, 1 independent
Updated Sep 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cellectis filed reports with the SEC and its stock was listed on Nasdaq on September 15, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cellectis
biopharmaceutical company
Nothing else this week.
-
SEC
Slovak company
-
Nasdaq
American fully electronic stock exchange
Related events
- Linde PLC filed reports with the Securities and Exchange Commission and was listed on the Nasdaq stock exchange.
- Monolithic Power Systems filed disclosures with the SEC, listed on Nasdaq, and saw Royal Bank of Canada increase its stock stake.
- Global Interactive Technologies, Inc. was listed on the electronic stock exchange and required to file disclosures with the SEC on August 15, 2026.
- Simwon America Corp. debuted on Nasdaq and filed with the SEC, with WallachBeth Capital running the book on the deal.
- GT Biopharma filed with the SEC regarding institutional investment, and its stock traded on the Nasdaq exchange.